Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
 
  • Details
Options

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis

Journal
PLOS ONE
Journal Volume
15
Journal Issue
12
Start Page
e0243783
ISSN
1932-6203
Date Issued
2020-12-14
Author(s)
Fu-Shun Yen
Jung-Nien Lai
James Cheng-Chung Wei  
Lu-Ting Chiu
Chii-Min Hwu
Ming-Chih Hou
Chih-Cheng Hsu
Editor(s)
Tatsuo Kanda
DOI
10.1371/journal.pone.0243783
URI
https://scholars.csmu.edu.tw/handle/123456789/4102
Abstract
<jats:p>This study aimed to investigate the long-term outcomes of sulfonylurea (SU) use in patients with T2DM and compensated liver cirrhosis. From January 1, 2000, to December 31, 2012, we selected the data of 3781 propensity-score-matched SU users and nonusers from Taiwan’s National Health Insurance Research Database. The mean follow-up time for this study was 5.74 years. Cox proportional hazards models with robust sandwich standard error estimates were used to compare the risks of main outcomes between SU users and nonusers. The incidence of mortality during follow-up was 3.24 and 4.09 per 100 person-years for SU users and nonusers, respectively. The adjusted hazard ratios and 95% confidence intervals for all-cause mortality, major cardiovascular events, and decompensated cirrhosis in SU users relative to SU nonusers were 0.79 (0.71–0.88), 0.69 (0.61–0.80), and 0.82 (0.66–1.03), respectively. The SU-associated lower risks of death and cardiovascular events seemed to have a dose–response trend. This population-based cohort study demonstrated that SU use was associated with lower risks of death and major cardiovascular events compared with SU non-use in patients with T2DM and compensated liver cirrhosis. SUs may be useful for glycemic management for patients with liver cirrhosis.</jats:p>
SDGs

[SDGs]SDG3

Publisher
Public Library of Science (PLoS)
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback